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In resistant plants, pathogen attack often leads to rapid
activation of defense responses that limit multiplication
and spread of the pathogen. To investigate the signaling
mechanisms underlying this process, we carried out a
screen for mutants in the signaling pathway governing resistance in Arabidopsis thaliana to the bacterial pathogen
Pseudomonas syringae. This involved screening for suppressor mutations that restored resistance to a susceptible
line carrying a mutation in the RPS2 resistance gene. A
mutant that conferred resistance by activating defense responses in the absence of pathogens was isolated. This mutant, which carries a mutation at the CPR5 locus and was
thus designated cpr5-2, exhibited resistance to P. syringae,
spontaneous development of necrotic lesions, elevated PR
gene expression in the absence of pathogens, and abnormal trichomes. Resistance gene-mediated defenses, including the hypersensitive response, restriction of pathogen growth, and induction of defense-related gene
expression, were functional in cpr5-2 mutant plants. Additionally, in cpr5-2 plants RPS2-mediated induction of PR-1
expression was enhanced, whereas RPM1-mediated induction of ELI3 was not. These findings suggest that CPR5
encodes a negative regulator of the RPS2 signal transduction pathway.
Additional keywords: disease lesion mimic, gl3, systemic acquired resistance (SAR).
Disease resistance in plants is often triggered by specific
recognition of the invading pathogen. Pathogen recognition
results in the rapid activation of a complex series of plant defense responses that limit multiplication and spread of the
pathogen within the plant, thus leading to resistance. Common
defense responses include the production of reactive oxygen
species, the hypersensitive response (HR), which is characterized by rapid cell death and tissue necrosis at the site of
infection, and the production of antimicrobial compounds
(phytoalexins) and lytic enzymes (reviewed in HammondKosack and Jones 1996; Baker et al. 1997; Greenberg 1997).
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Many of these induced responses are controlled, at least in
part, by transcriptional activation of defense-related genes,
including the pathogenesis-related (PR) genes (Lamb et al.
1989; Baker et al. 1997).
Pathogen recognition is governed by genes in both the plant
and the pathogen (Keen 1990). Plant disease resistance genes
confer on the plant the ability to recognize pathogens expressing specific recognition determinants. Production of
these pathogen determinants is, in turn, controlled by specific
pathogen avirulence (avr) genes. The prevailing hypothesis is
that the recognition event mediated by matching resistance
and avr genes triggers a signal transduction pathway that culminates in the activation of plant defense responses. The molecular isolation of several disease resistance genes has revealed that the majority cloned to date appear to encode
components of signal transduction pathways (Bent 1996;
Hammond-Kosack and Jones 1997). For example, the RPS2
gene of Arabidopsis thaliana, which confers resistance to
strains of the bacterial pathogen Pseudomonas syringae expressing avrRpt2 (Kunkel et al. 1993; Yu et al. 1993), encodes
a protein containing several motifs suggestive of a role in signaling, including a leucine-rich repeat (LRR) domain and a
nucleotide-binding site (Bent et al. 1994; Mindrinos et al.
1994). However, the actual mechanisms by which RPS2 and
other resistance genes mediate resistance are not clear. A current area of intense research is focused on further elucidating
the regulatory mechanisms governing resistance by identifying and characterizing additional components of disease resistance signal transduction pathways.
A number of genetic approaches have been used to further
dissect disease resistance signaling pathways (reviewed in
Dangl et al. 1996; Kunkel 1996; Ryals et al. 1996; Delaney
1997). These include screens for mutants that exhibit enhanced disease susceptibility (eds mutants; Glazebrook et al.
1996; Rogers and Ausubel 1997), mutants that have lost
genotype-specific resistance to avirulent pathogens (ndr1 and
eds1; Century et al. 1995; Parker et al. 1996), mutants that
either don’t induce (npr1, niml; Cao et al. 1994; Delaney et al.
1995) or inappropriately regulate defense-related gene expression (cpr, cim mutants; Lawton et al. 1993; Bowling et al.
1994, 1997), and mutants that form HR-like necrotic lesions
in the absence of pathogen infection (acd2 and lsd mutants;
Dietrich et al. 1994; Greenberg et al. 1994; Weyman et al.
1995). The acd2, lsd, and cpr5 mutants are examples of a

mutant class known as “disease lesion mimics” that behave as
if they were under constant pathogen attack. These mutants
often exhibit elevated levels of salicylic acid (SA), defenserelated gene expression in the absence of pathogens or SAinducing compounds, and enhanced resistance to a number of
bacterial and fungal pathogens. It is likely that these mutants
define genes encoding signaling components regulating the
induction or containment of HR-related cell death in response
to pathogen attack (Dangl et al. 1996; Ryals et al. 1996; Delaney 1997).
It is not yet clear whether resistance signaling pathways interact with other signal transduction processes in plants. The
isolation of several A. thaliana mutants with pleiotropic phenotypes such as ttg, which affects both trichome development
and anthocyanin production (Marks 1997), and several cop
and det mutants that affect photomorphogenesis and the regulation of defense gene expression (Mayer et al. 1996), provides evidence for cross-talk between signaling pathways
governing seemingly unrelated processes. As disease resistance signal transduction pathways become better understood,
interactions between the signaling pathways governing pathogen defense and other processes, including development, may
be revealed.
We have used a complementary genetic approach to dissect
the signal transduction pathway coupling pathogen recognition to expression of disease resistance in A. thaliana. This
involved screening for mutants that restore resistance to an
rps2 mutant line that is susceptible to P. syringae strains expressing avrRpt2 (Kunkel et al. 1993). Our expectation was
that this screen would identify mutants that restore RPS2dependent resistance as well as mutants that bypass the requirement for pathogen recognition. One of the suppressors
isolated in this screen carries a mutation at the CPR5 locus
(Bowling et al. 1997), and was thus designated cpr5-2. This
mutant exhibits an intriguing combination of phenotypes, including enhanced resistance to P. syringae, spontaneous development of necrotic lesions in uninoculated plants, and abnormal trichomes. We show that disease resistance mediated
by the RPS2, RPS5, and RPM1 genes is functional in the cpr52 mutant background and that cpr5-2 specifically enhances the
induction of PR-1 gene expression triggered by RPS2mediated pathogen recognition.
RESULTS
Isolation of mutations that suppress
the disease-susceptible phenotype of rps2 mutant plants.
We carried out a screen for A. thaliana mutants that suppress the disease-susceptible phenotype of an rps2 mutant in
order to identify additional genes important for resistance to
the bacterial pathogen P. syringae. To facilitate isolation of
components of the RPS2-mediated recognition pathway we
screened for mutants with enhanced resistance after inoculation with a P. syringae strain expressing the avirulence gene
avrRpt2.
As shown in Figure 1, wild-type A. thaliana ecotype Columbia (Col-0) plants were susceptible to the P. syringae pv.
tomato (Pst) strain DC3000 and developed bacterial specklike disease symptoms consisting of many small, individual
gray lesions surrounded by a halo of chlorosis. In contrast,
Col-0 plants (which possess a functional RPS2 gene; Kunkel

et al. 1993), were resistant to Pst DC3000 expressing the
avirulence gene avrRpt2 (Pst DC3000 [avrRpt2]) and thus
exhibited no disease symptoms. rps2 mutant plants were susceptible to both Pst DC3000 and Pst DC3000 (avrRpt2). To
isolate mutations that suppress the disease-susceptible phenotype of rps2 mutants, populations of M2 plants derived from
seed of rps2 mutant plants that had been mutagenized with
ethylmethane sulfonate (EMS) were inoculated with Pst
DC3000 (avrRpt2). We screened approximately 17,500 M 2
plants and isolated 28 suppressor mutant lines that exhibited
enhanced resistance upon re-testing in the M3 generation. One
of the most resistant of these suppressor mutants, cpr5-2, was
chosen for further analysis. The remaining 27 suppressor lines
are currently being characterized, and will be described in
more detail elsewhere (G. Kalinowski, A. Kloek, M. Verbsky,
and B. Kunkel, unpublished results).
cpr5-2 confers full resistance to P. syringae.
In contrast to the parental rps2 line, the cpr5-2 rps2 suppressor mutant line was resistant when inoculated with Pst
DC3000 (avrRpt2) (Fig. 1). To determine whether resistance
was restored specifically to Pst DC3000 (avrRpt2), we tested
cpr5-2 rps2 for resistance to several pathogenic P. syringae
strains not expressing avrRpt2, including Pst DC3000, Pst
3455 (Whalen et al. 1991), and the P. syringae pv. maculicola
(Psm) strain m4 (Debener et al. 1991). cpr5-2 rps2 mutant
plants were resistant to all three of these strains (Fig. 1; and
data not shown). This indicates that enhanced resistance in
cpr5-2 rps2 plants is not specific to strains expressing
avrRpt2, suggesting that resistance in this mutant line is independent of avrRpt2-mediated pathogen recognition. Furthermore, these observations suggest that resistance in the cpr5-2
rps2 line is not due to gain of a novel capacity to specifically
detect infection by Pst DC3000.
To determine if resistance in cpr5-2 rps2 was associated
with restricted growth of P. syringae within the plant, growth
of the pathogen in mutant plants was monitored over the
course of several days. As shown in Figure 2A, growth of Pst
DC3000 (avrRpt2) was limited in cpr5-2 rps2 mutant plants,
obtaining a final concentration of only 104 to 105 CFU/cm2.
This was in marked contrast to the high levels of bacterial
growth observed in CPR5 rps2 plants, where the same strain
reached a final concentration of 106 to 107 CFU/cm2 (Fig. 2A).
The 50- to 100-fold reduction of bacterial growth observed in
cpr5-2 rps2 plants was similar to the limitation of growth observed in wild-type Col-0 plants, where restriction of the
pathogen was a result of resistance gene-mediated pathogen
recognition (Fig. 2A). Pst DC3000, which grew to high levels
in wild-type Col-0 plants, was similarly restricted in cpr5-2
rps2 mutant plants (Fig. 2B).
cpr5-2 plants develop spontaneous lesions
prior to infection.
The cpr5-2 rps2 mutant was initially isolated based on its
enhanced resistance to Pst DC3000. Upon closer inspection
we observed that uninoculated cpr5-2 rps2 plants developed
macroscopic, localized, yellow or brown necrotic lesions,
reminiscent of those observed during an HR. Lesion formation
in cpr5-2 mutant plants was, at least in part, developmentally
regulated, as tissue necrosis initially appeared on cotyledons
of 2- to 3-week-old seedlings, followed by chlorosis and grad-
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ual necrosis of the entire cotyledon. As shown in Figure 3, as
the mutant plants matured, chlorotic and necrotic lesions became apparent on the older leaves. Necrosis often started at
the base of the midrib, and then extended into the leaf (Fig.
3B). Development of this lesion-mimic phenotype was independent of pathogen attack, as lesion development also occurred on seedlings grown in axenic culture (data not shown).

We noted variation in lesion development from experiment
to experiment, but this variability was not strongly dependent
on day length or light intensity (data not shown). However,
high humidity appeared to delay the formation of macroscopic
lesions. Visible tissue necrosis was not evident until 3 to 4
weeks after germination in seedlings grown under the very
humid conditions present in axenic culture (data not shown).
cpr5-2 rps2 mutant plants were also somewhat smaller than
their CPR5 rps2 progenitor or their wild-type siblings. The
reduction in plant size, which was reflected both in overall
stature of the plant (data not shown) and in leaf size (Fig. 3B),
was evident both in seedlings grown under axenic conditions
and in those grown in soil.
cpr5-2 mutants have abnormal trichomes.
A third phenotype of cpr5-2 rps2 mutant plants was abnormal trichomes. As illustrated in Figure 4, trichomes on the
leaves of cpr5-2 mutants were much smaller than trichomes
present on wild-type plants. In addition, the majority of cpr5-2
trichomes had only two branches, while wild-type trichomes
typically had three or four (Fig. 4; Hülskamp et al. 1994;
Marks 1997). However, the spacing and number of trichomes
per leaf appeared to be unaltered. The mutant trichomes also
had a transparent, “glassy” appearance, and lacked the calcium-containing papillae found in the mature secondary cell
wall of wild-type trichomes (data not shown; Marks 1997).
Additional phenotypes often associated with trichome mutations, such as alterations in production of seed coat mucilage
and root hair development, appeared to be normal in cpr5-2
mutant plants (data not shown).

Fig. 1. Disease phenotypes of wild-type Col-0 (CPR5 RPS2), CPR5
rps2, and cpr5-2 rps2 mutant Arabidopsis thaliana plants after inoculation with Pseudomonas syringae pv. tomato (Pst) strains. Leaves are
shown 4 days after inoculation with Pst DC3000 (top) or Pst DC3000
(avrRpt2) (bottom). Plants were inoculated by dipping into bacterial
suspensions containing the surfactant Silwet L-77.

Genetic analysis of cpr5-2.
To determine the genetic basis of the disease resistance, lesion-mimic, and abnormal trichome phenotypes in the cpr5-2
rps2 mutant line, we crossed the mutant to both CPR5 rps2
plants and wild-type Col-0, which carries a functional RPS2
gene. As is summarized in Table 1, the F1 progeny from both

Fig. 2. Growth of Pseudomonas syringae pv. tomato (Pst) strains in suppressor mutant cpr5-2. Six-week-old Arabidopsis thaliana plants were inoculated
by vacuum infiltration with the indicated Pst strains and the concentration of bacteria in the plant leaves assayed after 0, 2, and 4 days. A, Growth of Pst
DC3000 (avrRpt2) in the indicated A. thaliana lines, B, Growth of Pst DC3000 and Pst DC3000 (avrRpt2) in Col-0 (CPR5 RPS2) and cpr5-2 RPS2
plants. C, Growth of Pst DC3000, Pst DC3000 (avrRpm1), and Pst DC3000 (avrPphB) in wild-type Col-0 and cpr5-2 plants. Data points represent
means of three independent determinations ± SEM. Data presented in A and B are from the same experiment; thus, results for Pst DC3000 (avrRpt2)
growth in Col-0 and cpr5-2 RPS2 are presented in both panels for direct comparison. Experiments presented in A and B were repeated a minimum of
three times with similar results.
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crosses were susceptible to Pst DC3000, indicating that the
cpr5-2 mutation is recessive. The F1 plants were allowed to
self-pollinate and the resulting F2 progeny were assayed to
determine the segregation pattern of resistance conferred by

Fig. 3. Disease lesion-mimic phenotype of cpr5-2 mutant plants. A,
Uninfected cpr5-2 plants exhibited macroscopic necrotic lesions on
older rosette leaves. B, Lesion-positive leaf from uninfected cpr5-2 plant
(top) and leaf from uninfected wild-type CPR5 plant (bottom). The
leaves in B are developmentally matched and were taken from plants of
the same age.

the cpr5-2 mutation. In the F2 progeny from both crosses resistance segregated as a recessive, single-gene trait (Table 1).
The lesion-mimic and abnormal trichome phenotypes cosegregated with resistance in these crosses (Table 1). Additionally, in 452 cpr5-2 F2 progeny from a cross between cpr5-2
and Landsberg erecta (La-er), we did not detect any recombinant plants in which the lesion-mimic and trichome phenotypes were separated, indicating that these phenotypes are
conferred by a defect at a single locus, or at two very tightly
linked loci. The conclusion that all three phenotypes are due to
mutation of a single locus is strengthened by the fact that an A.
thaliana mutant exhibiting similar lesion-mimic and abnormal
trichome development phenotypes was isolated in an independent screen. This mutant, cpr5 (now referred to as cpr5-1), was
isolated in a screen for mutants with elevated expression of the
BGL2 promoter, and was thus assigned the cpr (constitutive expressor of PR genes) designation (Bowling et al. 1997). Complementation tests between cpr5-1 and cpr5-2 indicated that the
two mutants are allelic (data not shown; Bowling et al. 1997).
The abnormal cpr5-2 trichome phenotype most closely resembles that observed for the gl3 trichome mutant. The leaves
of gl3 mutant plants also have short, mostly unbranched
trichomes (Marks 1997). Although gl3 mutant plants do not
exhibit the lesion-mimic or enhanced resistance phenotypes
observed in cpr5-2 (data not shown), it was possible that cpr52 was an unusual allele of gl3. To investigate this possibility
the cpr5-2 rps2 mutant was crossed to gl3 and the resulting F1
and F2 progeny scored for their resistance, lesion-mimic, and
trichome phenotypes. The F1 progeny exhibited wild-type
phenotypes for all three traits, indicating that gl3 and cpr5-2
are not allelic. In addition, the random segregation of the resistance and lesion-mimic phenotypes from the gl3 phenotype
among the F2 progeny indicated that the GL3 and CPR5 loci
are unlinked (Table 1; and data not shown).
To determine the map position of the CPR5 locus we took
advantage of the fact that the gl3 mutant used in the complementation test was in the La-er background (Table 1). F2
progeny from this cross were used to map cpr5-2 relative to
selected molecular markers positioned at intervals of 20 to 40
centiMorgans (cM) on each of the five chromosomes
(Konieczny and Ausubel 1993; Bell and Ecker 1994). As
summarized in Table 2, cpr5-2 mapped to chromosome 5, in
an approximately 7 cM interval between the markers g2368
and m555. Although we mapped cpr5-2 to the same region of
chromosome 5 reported for cpr5-1 by Bowling et al. (1997),
we place cpr5-2 between g2368 and m555.
Based on complementation tests and map position, cpr5-2
defines a new locus affecting trichome development. Genetic
analysis indicates that the cpr5-2 mutation is not an allele of
the gl2, gl3, an, try, sti, or zwi loci, which are known to affect
trichome development (J. Larkin, unpublished results; Hülskamp et al. 1994; Oppenheimer et al. 1997).
Resistance gene-mediated induction of defense responses
is functional in cpr5-2 mutant plants.
We next wanted to address whether resistance genemediated resistance was altered, or possibly enhanced, by the
presence of the cpr5-2 mutation. Our finding that the cpr5-2
resistance phenotype was expressed both in plants carrying the
rps2 mutation and in plants with a functional RPS2 gene
(Table 1) indicates that the cpr5-2 mutation does not behave
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as an allele-specific suppressor mutation. Further, the generation of homozygous cpr5-2 RPS2 lines facilitated the investigation of any possible effects that the cpr5-2 mutation may
have on RPS2-mediated disease resistance.
We monitored the activities of RPS2, as well as two other
resistance genes, by assaying for both expression of the HR
and restriction of pathogen growth in cpr5-2 RPS2 plants.
Wild-type Col-0 plants carry functional RPS2, RPM1, and
RPS5 genes and exhibited visible macroscopic tissue collapse
indicative of an HR within 20 h after inoculation with high
doses of Pst DC3000 expressing avrRpt2, avrRpm1, or
avrPphB (data not shown; Debener et al. 1991; Kunkel et al.
1993; Simonich and Innes 1995). cpr5-2 RPS2 plants also exhibited clear HRs when inoculated with these strains (data not
shown). The timing of the HRs observed in these plants was
the same as that observed in wild-type Col-0. However, the
degree of tissue collapse was reduced by varying degrees in
all three interactions (data not shown). Neither cpr5-2 RPS2
plants inoculated with Pst DC3000 nor cpr5-2 rps2 plants in-

oculated with Pst DC3000 or Pst DC3000 (avrRpt2) exhibited
an HR. These results indicate that, as in wild-type plants, the
HR in cpr5-2 plants is dependent on the presence of both the
bacterial avr gene and the corresponding resistance gene.
Further, the absence of an HR in cpr5-2 plants inoculated with
Pst DC3000 suggests that enhanced resistance conferred by
cpr5-2 is independent of the elicitation of an HR.
Additional evidence that resistance gene-mediated resistance is functional in the context of cpr5-2 stems from the
finding that in cpr5-2 RPS2 plants growth of Pst DC3000 expressing avrRpt2 is 50- to 100-fold lower than that observed
in cpr5-2 rps2 plants (Fig. 2A). These results indicate that in
the cpr5-2 mutant background RPS2-mediated resistance is
functional and confers additional resistance to Pst DC3000
(avrRpt2). However, given the recent finding that avrRpt2 acts
as a virulence factor by promoting pathogen growth in plants
lacking a functional RPS2 gene (A. P. Kloek, M. Lim, and B.
N. Kunkel, unpublished results), we were concerned that the
difference in growth of Pst DC3000 (avrRpt2) in cpr5-2 rps2

Fig. 4. Trichome phenotype of cpr5-2 mutant plants. A, Wild-type CPR5 (Col-0). B, cpr5-2. A and B, Printed at ×140. Bars = 100 µm.
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and cpr5-2 RPS2 plants might be enhanced by the avrRpt2
virulence activity. Thus, we also assayed RPS2 function by
comparing the growth of Pst DC3000 and Pst DC3000
(avrRpt2) in cpr5-2 RPS2 plants. As is shown in Figure 2B,
growth of Pst DC3000 in cpr5-2 RPS2 plants is 100-fold
lower than in wild-type plants. The growth of Pst DC3000
(avrRpt2) in cpr5-2 RPS2 plants is reduced an additional fourto 10-fold (Fig. 2B; and data not shown), confirming that
avrRpt2/RPS2-mediated resistance is functional in cpr5-2
plants. In contrast to the experiments summarized in Figure
2A, a cumulative effect of resistance mediated by cpr5-2 and
by RPS2 was not reproducibly detectable in these experiments
(Fig. 2B; and data not shown).
RPM- and RPS5-mediated resistances are also functional in
the presence of the cpr5-2 mutation. The growth of Pst
DC3000 (avrRpm1), Pst DC3000 (avrB), and Pst DC3000
(avrPphB) was significantly lower than the growth observed
for Pst DC3000 in cpr5-2 plants (Fig. 2C; and data not
shown). In these interactions resistance gene-mediated resistance was very effective in restricting pathogen growth (data
not shown), and thus any additional resistance conferred by
cpr5-2 was not detected in these experiments.

Defense-related PR genes are expressed in cpr5-2
in the absence of pathogens.
The enhanced resistance and lesion-mimic phenotypes of
cpr5-2 are reminiscent of the acd2 and lsd mutants described
previously (Dietrich et al. 1994; Greenberg et al. 1994; Weyman et al. 1995). In these mutants enhanced resistance is correlated not only with the spontaneous appearance of necrotic
lesions, but also with elevated defense-related gene expression. To determine whether this was also the case for cpr5-2
we monitored PR gene expression in uninfected plants by
RNA blot analysis. As is shown in Figure 5, the level of expression of two PR genes, PR-1 and BGL2, was undetectable
in leaves of mature, uninoculated wild-type Col-0 (CPR5
RPS2) and CPR5 rps2 plants. However, both genes were expressed at elevated levels in leaves of mature, uninoculated
cpr5-2 rps2 plants grown under the same conditions (Fig. 5A).
The level of PR gene expression was higher in leaves exhibiting lesions than in leaves without lesions harvested from the

Table 1. Genetic analysis of cpr5-2
Generation

Cross
cpr5-2 rps2 × CPR5 rps2
cpr5-2 rps2 × CPR5 RPS2 (Col-0)
cpr5-2 rps2 × CPR5 RPS2 gl3 (La-er)
cpr5-2 rps2 × CPR5 RPS2 nahG

Plants (no.)
Sa
b,c

Ra

Χ23:1

F1
F2

7
105b

0
31d

0.35

F1
F2

6c,e
66e

0
16d

1.32

F1
F2

2c,e
117e

0
44d

0.46

F1
F2

f

ND
2d

ND
91e

2.66g

a

Plants were inoculated by dipping them into bacterial suspensions
containing the surfactant Silwet L-77, and were scored 4 to 5 days after
inoculation. S = susceptible plants with disease symptoms; R = resistant plants exhibiting no disease symptoms.
b
Plants were scored for resistance to the Pseudomonas syringae pv. tomato (Pst) strain DC3000 (avrRpt2).
c
F1 plants had wild-type trichomes and did not exhibit necrotic lesions.
d
All resistant plants exhibited necrotic lesions and had abnormal
trichomes.
e
Plants were scored for resistance to Pst DC3000.
f
Not determined.
g 2
Χ value for 15:1 segregation ratio.
Table 2. Linkage analysis of the CPR5 locus
Markera
DFR
LFY3
g2368
m555
a

Recombinant
chromosomesb
17
29
10
52

Chromosomes
scored (total no.)b
58
904
856
898

Recombination
frequency (%)
29c
3.2c
1.2c
5.8c

Other markers tested that showed no linkage to cpr5-2: GapB, nga111,
nga128, UFO, and PVV4 (chromosome 1); Gl1 and nga172 (chromosome 3); PG11(chromosome 4); nga151 and gl3 (chromosome 5).
b
Data obtained from F2 seedlings from the cross between rps2 cpr5-2
(Col-0) and gl3 (La-er)
c
Three-factor analysis indicates that cpr5-2 maps between g2368 and
m555.

Fig. 5. Expression of PR-1 and BGL2 in uninoculated cpr5-2 plants. A,
Total RNA was extracted from mature plants grown in soil and subjected
to RNA blot analysis. Lesion-positive (+) and lesion-negative (–) leaves
were sampled from the same cpr5-2 plants and RNA was prepared separately for each sample. B, Total RNA was extracted at indicated times
(days post germination; dpg) from CPR5 rps2 and cpr5-2 rps2 seedlings
grown axenically on Murashige and Skoog (MS) medium. Approximately 2 µg of RNA was loaded for each sample. Blots were first probed
with PR-1 and BGL2, followed by hybridization with an rDNA probe as
a loading control.
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same plant. Elevated PR gene expression was also detected in
cpr5-2 plants grown axenically on Murashige and Skoog (MS)
agar plates (Fig. 5B).
To determine whether PR gene expression was constitutive, or alternatively whether it was induced during seedling
development, we grew cpr5-2 rps2 mutant plants in axenic
culture, and harvested seedlings at 1, 2, 3, and 4 weeks after
germination. The seedlings were examined through a dissecting scope to determine whether visible lesions were present, and then assayed for PR-1 gene expression by RNA gel
blot analysis. PR-1 RNA was not detectable in 7-day-old
cpr5-2 seedlings but then was strongly induced by 15 days
after germination (Fig. 5B). Macroscopic lesions did not appear until 21 days after germination. These results indicate
that both induction of PR-1 gene expression and lesion development in cpr5-2 rps2 plants are developmentally regulated and occur in the absence of pathogens or other microorganisms.
We also investigated whether enhanced disease resistance
and elevated levels of PR gene expression were dependent on
SA by analyzing progeny from a cross between cpr5-2 rps2
plants and an A. thaliana transgenic line carrying the bacterial
salicylate hydroxylase gene (nahG; Bowling et al. 1994). We
found that nahG is epistatic to cpr5-2 with respect to both enhanced resistance and elevated PR gene expression (data not
shown), indicating that cpr5-2 activates the defense response
signaling pathway at a point upstream of SA.
Pathogen recognition induces PR-1 gene expression
in cpr5-2 mutant plants.
To determine whether the cpr5-2 mutation also affects
pathogen-induced defense gene expression we infected cpr5-2
RPS2 plants with Pst DC3000 expressing either avrRpt2,

avrRpm1, avrB, or avrPphB and assayed for PR-1 gene expression at various time points after infection. As summarized
in Figure 6A, PR-1 expression was not detectable at early
points in the time course in CPR5 RPS2 plants, but then was
strongly induced between 6 and 12 h after infection with Pst
DC3000 (avrRpt2). This pattern of PR-1 induction is typical
of RPS2/avrRpt2-dependent defense responses (Reuber and
Ausubel 1996). PR-1 gene expression, which was slightly elevated in uninfected cpr5-2 plants (Fig. 5A) and in infected
cpr5-2 plants at early time points, was also strongly induced
between 6 and 12 h after infection, but reached significantly
higher levels than was observed in wild-type plants (Fig. 6A).
Interestingly, the elevated basal level of PR-1 gene expression
in cpr5-2 RPS2 plants did not significantly alter the timing of
avrRpt2/RPS2-mediated activation of PR-1. We observed this
significant enhancement of avrRpt2-induced PR-1 expression
in four separate experiments. This finding is consistent with
the observation that cpr5-2 RPS2 plants exhibited an HR with
normal kinetics when infected with Pst DC3000 (avrRpt2),
and may account for the additional reduction of pathogen
growth observed in cpr5-2 RPS2 mutants infected with Pst
DC3000 (avrRpt2) (Fig. 2A).
We did not detect significant induction of PR-1 in either
wild-type or cpr5-2 plants infected with Pst DC3000 expressing avrRpm1 or avrB (Fig. 6A). This is consistent with
previous reports that PR-1 is not induced upon infection with
P. syringae expressing avrRpm1 (Reuber and Ausubel 1996).
Thus, to assess RPM1-dependent activation of gene expression, we monitored induction of ELI3, a gene that is rapidly
and strongly induced during RPM1/avrRpm1-mediated resistance responses (Kiedrowski et al. 1992; Reuber and Ausubel
1996). ELI3 was rapidly induced in wild-type plants after infection with Pst DC3000 (avrRpt2), Pst DC3000 (avrRpm1),

Fig. 6. Expression of PR-1 and ELI3 in CPR5 RPS2 and cpr5-2 RPS2 plants after inoculation with Pseudomonas syringae pv. tomato (Pst). A, PR-1 expression. B, ELI3 expression. Total RNA was extracted from wild-type Col-0 (CPR5 RPS2; open squares) and cpr5-2 RPS2 (solid squares) leaves harvested at indicated times after vacuum infiltration with 5 × 105 CFU/ml of Pst DC3000, Pst DC3000 (avrRpt2), Pst DC3000 (avrRpm1), or Pst DC3000
(avrB). PR-1 and ELI3 hybridization signals were quantitated and normalized to signals obtained for the 28S rDNA. Similar results were obtained in a
second, independent experiment.
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and Pst DC3000 (avrB) (Fig. 6B). Interestingly, expression of
ELI3 in response to these strains was not enhanced in cpr5-2
plants. The reduction of ELI3 expression in response to Pst
DC3000 and Pst DC3000 (avrRpt2) in cpr5-2 plants was not
consistently observed. We found the pattern of induction of
PR-1 and ELI3 in response to Pst DC3000 (avrPphB) to be
variable (data not shown), and thus we could not draw any
meaningful conclusions from these experiments. The results
from these experiments indicate that the cpr5-2 mutation enhances the expression of PR-1 in response to RPS2-mediated
pathogen recognition, but does not effect ELI3 expression activated by the RPM1 signaling pathway.
DISCUSSION
Identification of a mutant with enhanced resistance
to P. syringae.
We have isolated a new mutant allele of CPR5 in a screen
for second-site mutations that restore resistance of an rps2
mutant line to Pst DC3000 expressing avrRpt2. The finding
that cpr5-2 plants were also resistant to Pst DC3000 not expressing avrRpt2 (Figs. 1 and 2) indicates that resistance in
this mutant is independent of RPS2-mediated pathogen recognition. Rather, resistance in cpr5-2 appears to be due to the
activation of defense responses in the absence of pathogen
recognition.
cpr5-2 mutants express defense responses in the absence
of pathogen infection.
cpr5-2 mutant plants exhibited two additional phenotypes
indicative of “de-regulated” expression of defense responses: spontaneous development of necrotic lesions and
expression of PR genes in the absence of pathogens. Defense-related genes, such as the PR genes, are not expressed
at high levels in uninfected wild-type A. thaliana plants.
Rather, expression of these genes is induced after pathogen
infection (Fig. 6; Ryals et al. 1996). In contrast, cpr5-2 mutant plants expressed elevated levels of the defense-related
genes PR-1 and BGL2 in the absence of pathogen infection
(Fig. 5A). Expression of these genes was highest in leaves
exhibiting visible necrotic lesions, but was also detectable at
lower levels in leaves without macroscopic lesions. These
results are consistent with the findings of Bowling et al.
(1997) for cpr5-1, and suggest that lesion formation in cpr5
plants results in activation of both localized and systemic
induction of systemic acquired resistance (SAR) gene expression, and thus disease resistance. This hypothesis is
supported by the fact that cpr5-1 mutant plants also exhibit
elevated levels of SA (Bowling et al. 1997).
The cpr5-2 phenotypes are reminiscent of the phenotypes of
acd2 and lsd mutants, where lesion formation leads to induction of PR gene expression and SAR (Dietrich et al. 1994;
Greenberg et al. 1994; Weyman et al. 1995). Surprisingly, we
found that in axenically grown cpr5-2 mutant seedlings, PR-1
gene expression preceded the appearance of visible lesions
(Fig. 5). One possible explanation for this observation is that
microscopic lesions were present prior to induction of PR-1
expression in cpr5-2 seedlings grown under these conditions.
Alternatively, a signal that induces both lesion formation and
PR-1 gene expression may have been present at between 1 and
2 weeks of age in these seedlings, but the environmental con-

ditions present in axenic plant culture caused a delay in lesion
formation.
CPR5 is a novel locus involved in disease resistance
and trichome development.
One of the most intriguing aspects of the cpr5-2 mutation is
that it also affects trichome development. cpr5-2 trichomes
are shorter and have fewer branches than those present on
wild-type plants (Fig. 4). Our genetic analysis of cpr5-2 suggests that enhanced disease resistance, lesion development,
and the unique trichome defect are conferred by a single, recessive mutation that maps to the lower arm of chromosome
5. The fact that the cpr5-1 mutant also has a similar trichome
defect (Bowling et al. 1997) lends support to our conclusion
that the trichome phenotype can be attributed to a mutation at
the CPR5 locus. The CPR5 locus is novel in that it is both important in disease resistance signal transduction and required
for normal trichome development.
RPS2, RPM1 and RPS5-mediated defense responses
are functional in cpr5-2 plants.
Resistance gene-mediated pathogen recognition is functional in the cpr5-2 mutant background. This conclusion is
supported by results from three different assays for resistance gene function. First, cpr5-2 plants exhibited HRs
when inoculated with high levels of Pst DC3000 expressing
avrRpt2, avrRpm1, or avrPphB. Second, avr gene-mediated
restriction of pathogen growth of Pst DC3000 expressing
avrRpt2, avrRpm1, avrB, or avrPphB was observed in cpr52 mutant plants (Fig. 2). Third, resistance gene-mediated
induction of defense gene expression was induced in cpr5-2
plants after infection with Pst DC3000 expressing these avr
genes (Fig. 6). These results indicate that the cpr5-2 mutation does not interfere with resistance gene-mediated signal
transduction.
In fact, the cpr5-2 mutation enhances RPS2-mediated signaling. In cpr5-2 plants infected with Pst DC3000 (avrRpt2),
induction of PR-1 expression was significantly higher than in
wild-type plants (Fig. 6). Interestingly, this stimulatory effect
of cpr5-2 appears to be specific for the RPS2 signaling pathway, as RPS5 and RPM1-mediated induction of defense genes
was not enhanced in the mutant. This result is not surprising
given the finding that RPS2 and RPM1 activate different signal transduction pathways leading to defense-related gene expression and resistance (Reuber and Ausubel 1996; Ritter and
Dangl 1996). It is entirely possible that different resistance
signaling pathways are regulated in different ways, and that
the cpr5-2 mutation affects only a subset of these.
Although RPS2- and cpr5-2-mediated activation of defense
responses is cumulative at the level of PR-1 expression, it is
difficult to detect enhanced resistance at the level of restriction of pathogen growth. This is presumably due to the fact that
resistance gene-mediated defense responses are very effective at
limiting pathogen growth, thus masking any additional resistance conferred by cpr5-2. However, we were able to measure
a significant cumulative resistance effect in the context of
plants carrying an rps2 mutation, in which growth of Pst
DC3000 is significantly enhanced by the presence of the
avrRpt2 gene (Fig. 2A). In this case, the cumulative effect of
RPS2 and cpr5-2-mediated defense responses can be monitored in pathogen growth assays.
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Possible roles for CPR5 in disease resistance signaling
pathways.
The results of our analysis of cpr5-2 agree with those reported
for cpr5-1 by Bowling et al. (1997). Consistent with their model
for the role of CPR5 in defense, we propose that cpr5-2 affects
an early step in the defense response signaling pathway, upstream of SA, and presumably downstream of pathogen recognition. However, our analysis of the interactions between cpr5-2
and several different resistance gene signaling pathways provides additional information that can be incorporated into a
model for how CPR5 may be regulating disease resistance.
The cpr5-2 mutant belongs to the “initiation class” of cell
death mutants, which Dangl et al. (1996) define as mutants
that “stochastically form lesions of determinate size at inappropriate locations.” In this class of mutants it is proposed that
the HR signaling pathway and, presumably, the defense response pathway are inappropriately regulated. Based on this
hypothesis we envision that the wild-type CPR5 gene product
normally acts as a negative regulator of one or more branches
of the pathogen response signaling cascade, preventing inappropriate flux through the pathway. Mutations at CPR5 would
either partially or entirely remove this level of control, resulting
in sensitization or inappropriate activation of the pathway. The
phenotype of the cpr5-2 mutant is consistent with this model,
as lesion development and the expression of PR genes are uncoupled from the normal induction by pathogen recognition.
In the case of the cpr5-2 mutant, however, the resistance
signaling pathways are still capable of responding to positive
inputs such as pathogen recognition mediated by the resistance genes RPS2, RPM1, and RPS5. Interestingly, cpr5-2 appears to specifically potentiate signaling through the RPS2
pathway, as PR-1 expression in response to Pst DC3000
(avrRpt2) is significantly enhanced in the mutant. This finding
suggests that CPR5 impinges on RPS2 signaling, but does not
directly modulate the RPM1 pathway.
An alternative hypothesis is that the cpr5-2 mutation gives
rise to an alteration in cellular metabolism that indirectly results in abnormal trichome development, lesion formation,
elevated SA levels, expression of PR genes, and the resulting
resistance. In this scenario, elevated levels of SA could potentiate enhanced signaling through the RPS2 pathway (Shirasu
et al. 1997). Thus, cpr5-2 could be a mutation in a gene not
normally involved in disease resistance or trichome development. A third possibility is that CPR5 may be required for the
normal function of a cellular component, such as the plant cell
wall, that plays an important role in both disease resistance
signaling and trichome development.
The molecular isolation and further characterization of
CPR5 should contribute to our understanding of both pathogen
resistance and trichome development, and is likely to lead to
important insights into how two seemingly separate processes
may be governed by a shared regulatory component.
MATERIALS AND METHODS
Bacterial strains and plasmids.
The bacterial pathogen strains Pseudomonas syringae pv.
tomato (Pst) DC3000, Pst 3435, P. syringae pv. maculicola
m4, and the avrRpt2, avrRpm1, avrB, and avrPphB avirulence
genes, have been described previously (Staskawicz et al.
1987; Debener et al. 1991; Jenner et al. 1991; Whalen et al.
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1991; Innes et al. 1993; Kunkel et al. 1993; Ritter and Dangl
1995). P. syringae strains were cultured at 28°C in King’s B
medium (King et al. 1954) containing 50 µg of rifampicin per
ml plus appropriate antibiotics required for plasmid maintenance. The avrRpt2 gene was introduced into these P. syringae strains on plasmids pABL18, pLH12, or pV288 (Whalen
et al. 1991; Kunkel et al. 1993), and the avrRpm1, avrB, and
avrPphB genes were introduced on plasmids K48 (Debener et
al. 1991), pPSG0002 (Staskawicz et al. 1987), or pPPY424
(Fillingham et al. 1992), respectively. P. syringae strains not
expressing avr genes carried control plasmids pLAFR3 or
pVSP61 (vectors without insert).
Plant material, growth conditions,
and inoculation procedures.
The susceptible rps2-201C mutant used in this work was
described previously (Kunkel et al. 1993). The nahG transgenic line (Bowling et al. 1994) and the cpr5-1 mutant
(Bowling et al. 1997) were obtained from Scott Bowling and
Xinnian Dong (Duke University). A. thaliana plants were
grown from seed in growth chambers under an 8-h photoperiod at 24°C. Mass inoculation of plants was carried out by
dipping entire leaf rosettes of 3- to 5-week-old plants into
bacterial suspensions of 2 to 4 × 108 CFU/ml containing the
surfactant Silwet L-77 as described in Kunkel et al. (1993).
Pipette infiltrations to assay for the HR were carried out with
Pst strains suspended in 10 mM MgCl2 to a density of approximately 2 × 107 CFU/ml (Kunkel et al. 1993). Leaves
were scored for tissue collapse approximately 20 h after inoculation. Bacterial growth within leaf tissue was monitored
as described by Whalen et al. (1991).
Mutagenesis and isolation of mutants.
A genetically marked line of rps2-201C carrying a tightly
linked molecular marker, PG11, was chosen for the mutant
screen to facilitate verification of true suppressor mutants.
PG11, which maps within 0.5 cM of RPS2 (Bent et al. 1994),
was used both to confirm that the suppressor mutants were
derived from the originally marked rps2-201C mutant line and
to follow inheritance of the rps2-201C allele in subsequent
crosses. The rps2-201C marked line was derived from an F2
individual from a cross between the rps2-201C mutant (Col-0
background) and the Nossen (No-0) ecotype that carried a
crossover between the mutant rps2 locus and PG11.
Seeds from the marked rps2-201C line were mutagenized
by soaking them for 8 h at room temperature in 30 mM EMS.
Lots of approximately 30 M1 seeds were planted and harvested separately to obtain independent populations of M2
seed. Approximately 2,000 M2 seeds from each of 10 lots
were screened by the L-77 dip-inoculation procedure (Kunkel
et al. 1993).
The cpr5-2 RPS2 plants used in our experiments were from
homozygous F3 cpr5-2 RPS2 families derived from a second
backcross of cpr5-2 rps2 to CPR5 RPS2 (wild-type Col-0).
Families homozygous for the wild-type RPS2 allele were
identified by polymerase chain reaction screening with the
closely linked PG11 marker.
Genetic analysis and mapping.
The cpr5-2 rps2 mutant was crossed to both CPR5 rps2201C and wild-type Col-0 to determine the genetic basis of

resistance. Allelism tests were carried out by crossing to gl3
(La-er background; Koornneef et al. 1982) and cpr5-1
(Bowling et al. 1997). The F1 progeny from the cross to cpr51 retained the trichome, disease lesion mimic, and enhanced
resistance phenotypes characteristic of the mutants, indicating
that cpr5-2 and cpr5-1 are allelic. cpr5-2 was also crossed to a
transgenic La-er line carrying the nahG gene (Bowling et al.
1994). As the dominant nahG gene renders plants very susceptible to P. syringae (Delaney et al. 1994), the F1 progeny
from this cross were not assayed for their resistance phenotype. The F1 plants were allowed to self-pollinate, and the resulting F2 progeny were scored for their disease lesion mimic
and trichome phenotypes. Tissue was then harvested from individuals with cpr5-2 lesion-mimic and trichome phenotypes
for RNA isolation and gel blot analysis to monitor expression
of nahG, PR-1, and BGL2. F2 progeny from both cpr5-2 and
wild-type phenotypic classes were then inoculated with Pst
DC3000 to assay their resistance phenotypes.
Restriction fragment length polymorphism (RFLP) linkage
analysis with codominant cleaved amplified polymorphic
DNA sequences (CAPS; Konieczny and Ausubel 1993) and
simple sequence length polymorphism (SSLP; Bell and Ecker
1994) markers was performed with progeny from the cross
between cpr5-2 (in a Col-0/No-0 hybrid background) and gl3
(La-er background). Plant genomic DNA was isolated from
leaf tissue of F2 plants according to the procedure of Tai and
Tanksley (1990) with modifications as described in Kunkel et
al. (1993).
Scanning electron microscopy.
Samples fixed in FAA (3.7% formaldehyde, 50% ethanol,
5% acetic acid) were prepared for scanning electron microscopy by standard methods (Irish and Sussex 1990).
RNA isolation and analysis.
Total RNA was isolated from A. thaliana leaf tissue with
the RNeasy Plant RNA isolation kit (Qiagen, Valencia, CA).
RNA gel blot analysis was carried out according to Sambrook
et al. (1989). Hybridization probes were prepared by randomprimer DNA synthesis (Sambrook et al. 1989). The following
DNA probes were used: A. thaliana PR-1 cDNA obtained
from Ciba-Geigy (Uknes et al. 1992); A. thaliana BGL2
cDNA (Dong et al. 1991); A. thaliana ELI3 cDNA
(Kiedrowski et al. 1992); and nahG (Bowling et al. 1994). As
a loading standard we used a 3.7-kb EcoRI fragment from the
10-kb genomic region carrying A. thaliana rRNA genes
(Vongs et al. 1993). This probe was kindly provided by Eric
Richards (Washington University).
The RNA blots were analyzed with a PhosphorImager
(Molecular Dynamics, Sunnyvale, CA). The data summarized
in Figure 6 were obtained by volume integration of the hybridization signals obtained with the PR-1 or ELI3 probes
followed by normalization to the hybridization signals obtained with the rDNA probe.
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